HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoshi Umemura Selected Research

Calcium

2/2018The effects of anti-hypertensive drugs and the mechanism of hypertension in vascular smooth muscle cell-specific ATP2B1 knockout mice.
6/2017Enhancement of intrarenal plasma membrane calcium pump isoform 1 expression in chronic angiotensin II-infused mice.
5/2016Relationship Between Thickness of Calcium on Optical Coherence Tomography and Crack Formation After Balloon Dilatation in Calcified Plaque Requiring Rotational Atherectomy.
3/2013ATP2B1 and blood pressure: from associations to pathophysiology.
12/2007Sevelamer hydrochloride improves hyperphosphatemia in hemodialysis patients with low bone turnover rate and low intact parathyroid hormone levels.
1/2007[A case of theophylline induced hypercalcemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoshi Umemura Research Topics

Disease

47Hypertension (High Blood Pressure)
11/2019 - 01/2002
25Heart Failure
10/2017 - 03/2002
21Acute Coronary Syndrome
07/2017 - 06/2004
21Myocardial Infarction
01/2017 - 08/2002
18Chronic Renal Insufficiency
10/2017 - 09/2003
14Coronary Artery Disease (Coronary Atherosclerosis)
06/2016 - 01/2004
12Fibrosis (Cirrhosis)
08/2018 - 11/2007
9Proteinuria
05/2014 - 09/2003
9Essential Hypertension
03/2013 - 02/2002
8Cardiomegaly (Heart Hypertrophy)
08/2013 - 05/2003
7Body Weight (Weight, Body)
10/2017 - 09/2003
7Cardiovascular Diseases (Cardiovascular Disease)
07/2017 - 08/2003
7Insulin Resistance
03/2017 - 08/2004
7Infarction (Infarctions)
01/2017 - 01/2005
6Hypertrophy
08/2018 - 03/2005
6Albuminuria
06/2017 - 08/2005
6ST Elevation Myocardial Infarction
11/2016 - 05/2010
6Diabetic Nephropathies (Diabetic Nephropathy)
12/2012 - 01/2004
5Inflammation (Inflammations)
03/2017 - 12/2006
5Diabetes Mellitus
02/2017 - 09/2006
5Atherosclerosis
11/2016 - 11/2007
5Type 2 Diabetes Mellitus (MODY)
06/2016 - 08/2004
5Shock
01/2014 - 04/2006
5Rupture
11/2012 - 06/2004
4Ischemia
05/2017 - 08/2003
4Abdominal Obesity
03/2017 - 01/2013
4Hemorrhage
01/2017 - 06/2009
4Coronary Occlusion
02/2016 - 07/2006
4Atrial Fibrillation
01/2012 - 04/2002
3Thrombosis (Thrombus)
05/2017 - 11/2012
3Obesity
03/2017 - 01/2013
3Dyslipidemias (Dyslipidemia)
01/2017 - 04/2013
3Pathologic Constriction (Stenosis)
01/2016 - 04/2011
3Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2013 - 12/2003
3Renal Insufficiency (Renal Failure)
12/2012 - 02/2002
3Tachycardia (Tachyarrhythmias)
01/2010 - 11/2002
3Neoplasms (Cancer)
02/2007 - 10/2003
3Ventricular Fibrillation
07/2006 - 11/2003
2Ureteral Obstruction
06/2017 - 06/2013
2Cerebral Infarction
05/2017 - 08/2004

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
06/2017 - 03/2003
16Angiotensin IIIBA
06/2017 - 06/2004
15Glucose (Dextrose)FDA LinkGeneric
03/2017 - 03/2002
11Antihypertensive Agents (Antihypertensives)IBA
11/2019 - 01/2002
11Angiotensin Receptor AntagonistsIBA
01/2016 - 09/2003
11CreatinineIBA
01/2014 - 02/2002
9Type 1 Angiotensin ReceptorIBA
03/2017 - 03/2005
8SodiumIBA
10/2017 - 01/2006
8LipidsIBA
11/2016 - 01/2004
8Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2016 - 07/2004
7AngiotensinogenIBA
08/2018 - 08/2003
7Amlodipine (Norvasc)FDA LinkGeneric
01/2016 - 09/2003
7olmesartanIBA
10/2014 - 10/2008
6CalciumIBA
02/2018 - 01/2007
6Messenger RNA (mRNA)IBA
06/2017 - 02/2007
6Protein Isoforms (Isoforms)IBA
06/2017 - 05/2003
6SaltsIBA
01/2016 - 01/2006
6oxidized low density lipoproteinIBA
12/2015 - 03/2003
6Losartan (Cozaar)FDA LinkGeneric
01/2014 - 09/2003
6candesartanIBA
01/2012 - 03/2003
5aliskirenFDA Link
08/2018 - 01/2012
5CholesterolIBA
01/2017 - 03/2003
5Therapeutic UsesIBA
01/2016 - 10/2011
5Calcium Channel Blockers (Blockers, Calcium Channel)IBA
01/2014 - 09/2003
5AlbuminsIBA
01/2014 - 02/2002
5C-Reactive ProteinIBA
10/2011 - 10/2006
4DiureticsIBA
10/2017 - 01/2014
4IrbesartanFDA LinkGeneric
01/2016 - 10/2012
4ReninIBA
07/2014 - 01/2012
4Clopidogrel (Plavix)FDA Link
09/2013 - 06/2009
4Valsartan (Vals)FDA Link
03/2013 - 05/2009
4Troponin T (Troponin T1)IBA
01/2013 - 06/2005
4Insulin (Novolin)FDA Link
04/2011 - 01/2004
3Parathyroid Hormone (Parathormone)IBA
09/2018 - 01/2007
3AdipokinesIBA
03/2017 - 11/2007
3Brain Natriuretic Peptide (Natrecor)FDA Link
02/2016 - 01/2006
3Epithelial Sodium ChannelsIBA
01/2016 - 01/2012
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2016 - 10/2014
3Blood Glucose (Blood Sugar)IBA
08/2015 - 01/2005
3LDL CholesterolIBA
09/2013 - 10/2012
3AngiotensinsIBA
08/2013 - 01/2012
3LDL Lipoproteins (beta Lipoproteins)IBA
04/2013 - 03/2003
3Angiotensin II Type 1 Receptor BlockersIBA
03/2013 - 03/2003
3Biomarkers (Surrogate Marker)IBA
01/2013 - 08/2011
3Creatine Kinase (Creatine Phosphokinase)IBA
05/2010 - 01/2005
3AdiponectinIBA
04/2009 - 09/2006
2Renin InhibitorsIBA
08/2018 - 01/2016
2Nitric Oxide Synthase (NO Synthase)IBA
02/2018 - 07/2014
2Heparin (Liquaemin)FDA LinkGeneric
05/2017 - 02/2012
2Indicators and Reagents (Reagents)IBA
02/2017 - 01/2015

Therapy/Procedure

37Therapeutics
11/2019 - 06/2002
11Percutaneous Coronary Intervention
01/2017 - 03/2003
9Cardiac Resynchronization Therapy
10/2012 - 03/2002
8Renal Dialysis (Hemodialysis)
01/2014 - 06/2002
5Stents
05/2017 - 09/2004
5Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2017 - 01/2005
3Blood Component Removal (Apheresis)
04/2013 - 03/2003
3Continuous Ambulatory Peritoneal Dialysis (CAPD)
10/2008 - 06/2002
2Patient Readmission
07/2017 - 01/2017
2Nephrectomy
06/2017 - 01/2017